Retrospective analysis (2009–2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India

Kamalraj, N and Sathishkumar, M and Arunvignesh, M and Baskar, V and Jebarani, S and Amutha, A and Deepa, M and Shanthi Rani, C S and Chandru, S and Unnikrishnan, R and Anjana, R M and Harish, M and Mohan, V (2021) Retrospective analysis (2009–2017) of factors associated with progression and regression of non-alcoholic fatty liver disease (Hepatic steatosis) in patients with type 2 diabetes seen at a tertiary diabetes centre in Southern India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 15 (5). p. 102261. ISSN 18714021

[img]PDF
Restricted to MDRF users only. Others may ->

431Kb

Abstract

Aim: To identify the profiles and factors associated with progression/regression of ultrasound-derived hepatic steatosis with type 2 diabetes mellitus seen at a tertiary diabetes center in southern India. Methods: Participants were individuals with type 2 diabetes mellitus with at least two consecutive ultrasound measurements available. Hepatic steatosis was assessed using high-resolution B-mode ultrasonography. Admittedly ultrasonography has lower sensitivity and specificity, however, it is the only modality available in a routine clinical setting to screen for hepatic steatosis. Progression or regression of hepatic steatosis was assessed after a mean follow-up of 3.0 ± 2.1 years and correlated with clinical and biochemical parameters. Results: A total of 1835 participants with type 2 diabetes mellitus were studied, of whom 88.6% had some form of hepatic steatosis at baseline which included mild steatosis (grade 1) in 982 (53.5%), moderate steatosis (grade 2) in 628 (34.2%) and severe steatosis (grade 3) in 15 (0.8%). Hepatic steatosis progression, regression or no change in grade of hepatic steatosis were seen in 21.5%, 26.6% and 51.9% of participants. Increase in body weight, body mass index, glycated haemoglobin, serum triglycerides and gamma glutamyl transferase were the factors associated with progression of hepatic steatosis, whereas regression showed reduction in body weight, body mass index, fasting plasma glucose and glycated haemoglobin. Conclusion: Among South Indian type 2 diabetes patients with hepatic steatosis, severity of steatosis progressed in 1/3rd while it regressed in 1/4th. These retrospective data need proper ascertainment in controlled studies.

Item Type:Article
Official URL/DOI:http://dx.doi.org/10.1016/j.dsx.2021.102261
Uncontrolled Keywords:Glycated hemoglobin; Hepatic steatosis; Non-alcoholic fatty liver disease; Obesity; Progression; Regression; Type 2 diabetes
Subjects:Diabetes Epidemiology
Diabetology > Diabetes Mellitus Type 2
Divisions:Department of Epidemiology
Department of Diabetology
ID Code:1268
Deposited By:surendar radha
Deposited On:19 Oct 2021 12:19
Last Modified:19 Oct 2021 12:19

Repository Staff Only: item control page